Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Blog · Safety · Published 2026-08-10

BUD vs Expiration Date: Not the Same Thing — the Chart, the Rules, and Your GLP-1 Vial

No — "beyond-use date" and "expiration date" are not synonymous, and the distinction is the whole story of compounded-drug shelf life. An expiration date is set by a manufacturer after formal stability testing of a mass-produced drug — often years out. A BUD (beyond-use date) is assigned by the compounding pharmacy for your specific preparation, under USP standards, and is deliberately conservative — often weeks. Same label real estate, entirely different evidence behind the number. If a quiz or compliance test asks whether the terms are interchangeable: the answer is false.

The side-by-side that settles it

Expiration date vs beyond-use date · consumer summary
Expiration dateBeyond-use date (BUD)
Who sets itManufacturerCompounding pharmacy
Based onFormal stability studies of the marketed productUSP <795>/<797> frameworks + formulation-specific limits
Applies toFDA-approved manufactured drugsCompounded preparations
Typical horizonYearsDays to weeks (sterile injectables)
On a GLP-1Brand pens & Zepbound vialsEvery compounded semaglutide/tirzepatide vial

The 28-day question, answered precisely

"Does compounded GLP-1 really expire after 28 days?" conflates the two concepts. The molecule doesn't switch off at day 28 — but the BUD is where the pharmacy's sterility and potency assurance ends, and for an injectable, sterility is non-negotiable. Past the BUD you're not using a slightly-weaker drug; you're using an unwarranted one. The full framework — the USP chart, how pharmacies assign BUDs, and why yours might be shorter than any default — lives in the rebuilt beyond-use-dates guide; the purchasing consequence (multi-month shipments out-running their own dates) is in BUDs on multi-month plans.

What to do with the date on your vial

Three habits: read the BUD on arrival (with concentration, volume, and storage — the four label reads); plan your doses against it, because paid-for drug past the BUD is waste by design; and if a shipment lands with most of its BUD already burned, call the pharmacy before injecting — shipping-time consumption of the use window is a legitimate complaint, and pattern-level problems belong in a MedWatch report.

Frequently asked questions

Are beyond-use date and expiration date interchangeable?

No — false. Expiration dates come from manufacturer stability testing of mass-produced drugs; BUDs are pharmacy-assigned, USP-governed limits for compounded preparations, typically far shorter.

What does BUD mean on a prescription or vial?

Beyond-use date — the deadline after which the compounded preparation should not be used. It ends the pharmacy's sterility and potency assurance; the label date governs.

Why is my compounded GLP-1's date only a few weeks out?

Because sterile compounded injectables carry conservative USP <797>-framework BUDs, not manufacturer expiration dates. Weeks-scale dating from a licensed pharmacy is normal, not a defect.

Can I use a GLP-1 vial past its BUD?

Doing so transfers sterility and potency risk from the pharmacy's quality system to you — with an injectable, that's the risk that matters most. Treat the BUD as a hard stop.

Primary sources

USP General Chapters <795> and <797> (beyond-use-date frameworks); FDA — Human Drug Compounding. Consumer application per the site guide.

Written by

Compounded GLP-1 Guide editorial team
Consumer-focused coverage of the compounded GLP-1 market: pricing capture, plan-structure analysis, and regulatory tracking, published under the site's editorial standards.

Pricing fact-checked

Figures are captured from provider plan pages and primary documents on the dates shown, normalized to effective monthly cost, and carry per-figure evidence status in the evidence ledger.

Medical review

Clinical statements are sourced to FDA labeling, agency communications, and published trial results cited in each article. Named-reviewer sign-off is pending per the methodology — this site does not list a reviewer it doesn't have.

Independent & transparent

Independently operated by US Peptides Partners LLC. Rankings are editorial, computed from published pricing under the methodology, and are not for sale. Outbound provider links carry referral-tracking tags; no arrangement changes a ranking — if a provider out-scores the current leader on captured figures, the ranking changes.